Compositions:- Amoxycillin 200 mg + Clavulanic Acid 28.5 mg Description:- Runmox™-JR 228.5 Dry Syrup is a broad-spectrum pediatric antibiotic formulation containing a powerful combination of Amoxycillin and Potassium Clavulanate, designed to effectively treat a wide range of bacterial infections in infants and children. This medicine belongs to the penicillin group of antibiotics and is widely prescribed due to its proven safety, effectiveness, and high tolerance in pediatric patients. Amoxycillin works by inhibiting the formation of bacterial cell walls, thereby killing susceptible bacteria and stopping the spread of infection. However, some bacteria produce enzymes known as beta-lactamases that can reduce the effectiveness of antibiotics. The addition of Clavulanic Acid overcomes this problem by inhibiting these enzymes, ensuring that Amoxycillin remains active against resistant bacterial strains. This synergistic action makes Runmox™-JR 228.5 highly effective against both common and resistant pathogens. This dry syrup formulation is specifically developed for children, offering accurate dosing and easy administration. It comes with sterile water for reconstitution, ensuring proper preparation and consistent concentration of the oral suspension. The pleasant vanilla flavour enhances acceptability and compliance among children, reducing the difficulty often associated with administering antibiotics to young patients. After reconstitution, each 5 ml of the suspension delivers 200 mg of Amoxycillin and 28.5 mg of Clavulanic Acid, making it suitable for treating mild to moderate bacterial infections as prescribed by a physician. The medicine is indicated for infections of the respiratory tract, ear, nose, throat, skin, soft tissues, urinary tract, and dental infections caused by susceptible organisms. Runmox™-JR 228.5 Dry Syrup should be administered strictly under medical supervision. The dosage and duration of treatment depend on the child’s age, body weight, severity of infection, and clinical response. For best results, the suspension should be shaken well before each dose and the full course of therapy should be completed, even if symptoms improve earlier. For storage, the dry powder should be kept in a cool and dry place protected from moisture, at a temperature not exceeding 30°C. Once reconstituted, the suspension should be stored in a refrigerator and used within the recommended period. The product should not be frozen and any unused portion should be discarded after completion of the treatment course. Runmox™-JR 228.5 Dry Syrup is a trusted pediatric antibiotic that offers effective infection control, improved bacterial coverage, and enhanced patient compliance. When used as directed by a registered medical practitioner, it plays an important role in the safe and effective management of bacterial infections in children. Uses:- Runmox™-JR 228.5 Dry Syrup is indicated for the treatment of various bacterial infections, including:- *Upper and lower respiratory tract infections *Ear, nose, and throat (ENT) infections *Skin and soft tissue infections *Urinary tract infections *Dental and other susceptible bacterial infections Note:- To be used only on the advice of a registered medical practitioner.) Storage:- *Store in a cool, dry place protected from moisture. *Do not store above 30°C. *After reconstitution, keep refrigerated and use within 7 days. *Do not freeze. *Keep out of reach of children. Important Notes:- *For paediatric use only. *Shake well before use. *Do not use if the reconstituted suspension turns pale yellow to brown. *Schedule H Prescription Drug – to be sold by retail on the prescription of a registered medical practitioner only. Conclusion:- Runmox™-JR 228.5 Dry Syrup is an effective and reliable pediatric antibiotic formulation combining Amoxycillin and Potassium Clavulanate for the treatment of a wide range of bacterial infections. Its enhanced spectrum of activity, pleasant vanilla flavour, and easy-to-administer dry syrup form make it especially suitable for children. When used as directed by a healthcare professional, Runmox™-JR 228.5 provides safe, well-tolerated, and effective infection control while ensuring better compliance in pediatric patients. It is a trusted choice for physicians and caregivers seeking dependable antibacterial therapy for children.